当前位置:首页 - 行情中心 - 盘龙药业(002864) - 财务分析 - 利润表

盘龙药业

(002864)

  

流通市值:18.76亿  总市值:30.98亿
流通股本:6434.89万   总股本:1.06亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入716,232,654.94500,018,373.81225,625,209.86974,293,135.49
营业收入716,232,654.94500,018,373.81225,625,209.86974,293,135.49
二、营业总成本619,614,116.27435,896,564.04200,170,026.24849,465,982.92
营业成本299,307,906.46225,887,699.75114,243,787.63408,009,022.38
税金及附加7,372,550.184,839,715.051,949,467.4310,235,652.05
销售费用267,073,918.7174,997,542.6472,223,640.93362,741,691.34
管理费用41,096,360.5126,579,300.1812,194,484.5553,372,577.79
研发费用15,741,181.5710,619,580.973,280,480.4118,233,617.47
财务费用-10,977,801.15-7,027,274.55-3,721,834.71-3,126,578.11
其中:利息费用5,101,419.673,796,576.342,181,72713,915,304.21
其中:利息收入16,190,977.0610,908,980.635,940,588.2517,183,295.15
加:投资收益-1,167,004.81-105,195.043,128.75-112,624.39
资产处置收益-11,031.59-11,031.59-11,031.59-
资产减值损失(新)-839,847.16-346,003.61-64,584.68-241,199.24
信用减值损失(新)-3,907,731.94-4,027,687.2-1,815,375.48-4,475,516.5
其他收益7,292,558.123,424,344.381,472,682.673,024,337.67
营业利润平衡项目0000
四、营业利润97,985,481.2963,056,236.7125,040,003.29123,022,150.11
加:营业外收入371,933.67243,913.92244,100.94456,158.86
减:营业外支出715,651.83100,949.18116,546.54,298,520.56
利润总额平衡项目0000
五、利润总额97,641,763.1363,199,201.4525,167,557.73119,179,788.41
减:所得税费用13,126,744.88,328,293.833,355,252.0916,032,830.1
六、净利润84,515,018.3354,870,907.6221,812,305.64103,146,958.31
持续经营净利润84,515,018.3354,870,907.6221,812,305.64103,146,958.31
归属于母公司股东的净利润84,103,585.7954,254,541.6421,561,607.43101,163,536.29
少数股东损益411,432.54616,365.98250,698.211,983,422.02
(一)基本每股收益0.910.580.241.18
(二)稀释每股收益0.910.580.231.17
九、综合收益总额84,515,018.3354,870,907.6221,812,305.64103,146,958.31
归属于母公司股东的综合收益总额84,103,585.7954,254,541.6421,561,607.43101,163,536.29
归属于少数股东的综合收益总额411,432.54616,365.98250,698.211,983,422.02
公告日期2023-10-302023-08-242023-04-282023-04-22
审计意见(境内)标准无保留意见
TOP↑